eNeura
Manufacturing · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
101 W Dickman St Ste 900, Baltimore, Mar...Phone Number
(833) 499-9300Website
www.eneura.comRevenue
$16.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About eNeura
eNeura specializes in sTMS Migraine Therapy, a clinically proven, non-invasive treatment designed to stop migraine pain and prevent future attacks without the side effects associated with medication. Their innovative technology utilizes Single-Pulse Transcranial Magnetic Stimulation (sTMS) to target hyperactive nerves in the brain, providing both acute and preventative treatment options for patients aged 12 and older. The company aims to empower individuals suffering from migraines by offering personalized treatment solutions that enhance their quality of life. eNeura's products are particularly beneficial for those seeking alternatives to traditional medication for migraine management.Explore more
eNeura Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is eNeura your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when eNeura launches new products
Congratulate Masked Content for being promoted to Masked Content at eNeura
Website visits: Recent activity has been detected on your website
Click to see if eNeura had a recent Job posting/layoffs
Check out if eNeura is spiking on competitors!
Funding: Get notified immidiatlly once eNeura has new funding data
Check if eNeura has recently received funding, and reach out quickly before it becomes old news!
eNeura, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on eNeura recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined eNeura as Masked Content
Find more new buyers
Compare Similar Companies to eNeura
Compare insights from companies similar to eNeura, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
eNeura is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
eNeura is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about eNeura.
eNeura financials insights
Gather financial insights about eNeura, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2010
Other Financing Round
$3.9M
2012
Private Equity
$1M
2013
Multiple Rounds
$6M
2014
Debt
$1.7M
Private Equity
$6.4M
2015
Debt
$15M
2016
Debt
$3.3M
2020
Debt
$350K
eNeura Tech Stack
A closer look at the technologies used by eNeura
See more technologies
Most Recent Scoops
Person-Based
Person-Based
Funding
eNeura has received an SBA PPP loan for $350,000-1 million from Citibank, N.A., supporting the retention of 17 jobs.
Management Move
Executive Move
Executive Moves
New Hire
Executive Move
Executive Moves, New Hire
eNeura News & Media
eNeura Achieves Record-Breaking Sales and Announces Notice of Allowance for a New Patent on Prophylactic Treatment of Migraine Headache
Record sales in April accelerating the pathway to profitability New IP will lead the way in changing the way migraine headaches are addressed WEST PALM BEACH, Fla., April 26, 2024 /PRNewswire/ -- eNeura, a pioneering leader in therapeutic solutions, proudly announces a monumental...eNeura, Inc. Announces Hire of Donald Pearl as Chief Executive Officer
BALTIMORE, Feb. 25, 2020 /PRNewswire/ -- eNeura, Inc., a privately held medical technology company based in Baltimore, MD and San Jose, CA, announced today that Donald Pearl has joined the company as Chief Executive Officer. Mr. Pearl brings extensive experience in the fields of neurology...eNeura, Inc. Receives FDA Clearance for Acute Treatment and Prevention of Migraine in Children 12 Years of Age and Older
BALTIMORE, Feb. 27, 2019 /PRNewswire/ -- eNeura, Inc., a privately held medical technology company, announced today that it has obtained a new 510(k) clearance from the U.S. Food and Drug Administration (FDA). This new marketing clearance expands the product indication of acute and...Publication in Cephalalgia Indicates eNeura's sTMS Significantly Reduces Migraine Headache Frequency
BALTIMORE, April 3, 2018 /PRNewswire/ -- eNeura, Inc., a privately held medical technology company, announced today the publication of a study in the peer-reviewed journal, Cephalalgia, demonstrating the company's portable, Transcranial Magnetic Stimulation (sTMS) technology,...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding eNeura
Sign Up For FreeTo access detailed company insights
eNeura specializes in sTMS Migraine Therapy, a clinically proven, non-invasive treatment designed to stop migraine pain and prevent future attacks without the side effects associated with medication. Their innovative technology utilizes Single-Pulse Transcranial Magnetic Stimulation (sTMS) to target hyperactive nerves in the brain, providing both a... Read More
